Pro-doping Enhanced Games to debut in Las Vegas with Trump Jr backing
A controversial new Olympics-style sporting event where athletes will be permitted – and even encouraged – to use performance-enhancing drugs is set to debut in Las Vegas next May, organizers announced on Wednesday.
The inaugural Enhanced Games will take place 21–24 May 2026 at Resorts World on the Las Vegas Strip. Over four days, competitors will race, lift and swim with full access to drugs and therapies banned in virtually every other elite athletic setting.
Related: On your marks, get set, dope! Welcome to the Enhanced Games – the sporting event no one wants | Marina Hyde
Billed as a revolution in sport and science, the event aims to embrace what organizers call 'superhumanity' – a future where pharmaceutical and technological enhancement is normalized in elite competition. But while promoters cast it as a bold break from the past, critics are already raising alarms about safety, fairness and the fundamental integrity of sport.
'We are creating a new category of human excellence,' the Enhanced Games' promotional materials declare. 'A world where performance-enhancing drugs are used safely, openly, and under medical supervision.'
The pitch is simple but radical: rather than penalize athletes for using banned substances, normalize and study their use in a medically supervised environment. Under the Enhanced model, athletes can either compete naturally, follow independent enhancement protocols, or participate in a clinical trial using FDA-approved drugs designated as 'Investigational Medicinal Products'.
The event's founder, the London-based Australian entrepreneur Aron D'Souza, argues that current anti-doping policies are outdated and hypocritical. 'The Enhanced Games is renovating the Olympic model for the 21st century,' he said. 'In the era of accelerating technological and scientific change, the world needs a sporting event that embraces the future – particularly advances in medical science.'
Organizers promise extensive medical screening, individualized health profiling and oversight by independent scientific and ethics boards. But athletes will not be subject to traditional anti-doping tests. Instead, they must disclose what substances they're using – a model that some critics warn resembles 'don't ask, don't tell' for doping in sport.
The first Games will be held at Resorts World in Las Vegas and feature sprinting, swimming and weightlifting. Prize money is substantial: up to $500,000 per event, including a $1m bonus for breaking the 100m sprint or 50m freestyle world records.
That may not be a theoretical reward. In February, Greek-Bulgarian swimmer Kristian Gkolomeev recorded a time of 20.89sec in the 50m freestyle – 0.02sec faster than the official world record, which has stood since 2009 – reportedly while following an enhancement protocol for the first time. The swim, held at a certified pool under Olympic-level oversight, was filmed for a forthcoming promotional documentary.
Yet even this demonstration comes with caveats. Gkolomeev wore a full-body polyurethane suit not approved by Fina, swimming's international governing body. Organizers claim the suit was commercially available and not decisive in the performance – but its inclusion underscores the ethical gray areas the Enhanced Games are poised to explore.
More fundamentally, many observers are uneasy with the concept itself.
'As we have seen through history, performance-enhancing drugs have taken a terrible physical and mental toll on many athletes. Some have died,' the World Anti-Doping Agency said in a statement. 'Clearly this event would jeopardize [athletes' health and well-being] by promoting the abuse of powerful substances and methods that should only be prescribed, if at all, for specific therapeutic needs.'
Travis Tygart, CEO of the US Anti-Doping Agency, was even more blunt. 'It's a dangerous clown show, not real sport,' he said.
Related: 'Imagine if a 60-year-old broke Usain Bolt's record': the story behind the Enhanced Games, the Olympics where everyone dopes
The Enhanced Games are also attracting attention, and controversy, due to the event's supporters. The latest funding round, reportedly in the millions, includes investment from 1789 Capital, a firm led by Donald Trump Jr, Omeed Malik and Chris Buskirk. Other co-leads include Apeiron Investment Group and Karatage, a hedge fund with stakes in cryptocurrency and AI ventures. A video announcing the funding suggests Donald Trump's endorsement.
D'Souza described the involvement of Trump-aligned investors as a natural fit. 'I've had the great fortune of working alongside many members of the administration and other prominent figures of the Trump movement over the years,' he said in February. 'To know that some of the most significant figures in American social and political life support the Enhanced Games is more important to us than any investment.'
Peter Thiel, the tech billionaire known for his libertarian politics and backing of controversial biotech ventures, is also listed as a major investor and 'close advisor', according to D'Souza.
The participation of such figures has drawn further scrutiny from critics who view the Enhanced Games as not only a break from the Olympic model, but a calculated provocation – a challenge to elite sporting institutions, anti-doping agencies and what D'Souza has called the 'anti-science' bent of legacy sports governance.
Organizers maintain they are not trying to overwrite Olympic records or discredit traditional sport. Instead, they frame the Enhanced Games as a parallel category, akin to the professionalization of sport in the 20th century. The goal, they argue, is to explore the boundaries of human potential while provoking a broader cultural conversation.
It's an ambitious vision – and a high-stakes gamble.
Athletes from around the world are being recruited, including some who felt alienated by anti-doping regimes. Former swimming world champion James Magnussen is among them, though the Australian's recent enhanced attempts fell short of record times.
The organizers, now headquartered in New York, say they will not tolerate abuse of illicit substances. Drugs must be legally prescribed and athletes must be medically fit to compete. Still, enforcement appears to rely more on partnership than oversight – a feature, not a bug, according to the Enhanced team.
'There are always risks in elite sport,' reads one of the Games' internal FAQs. 'We believe the greater risk is pretending those risks don't exist.'
Whether the public buys into that logic remains to be seen. Organizers say they are in talks with major sponsors and streaming platforms, but have not confirmed any broadcast partners or marquee athletes beyond a handful of early adopters. If backlash builds – from federations, governments or regulators – it's unclear whether the model will survive its first test.
For now, though, the Enhanced Games are moving ahead, armed with a defiant slogan: Live Enhanced.
Whether the world embraces that vision or recoils from it may determine not just the future of one event, but the ethical limits of sport itself.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Emulate Launches AVA™ Emulation System to Accelerate Drug Development With First-of-its-Kind High-Throughput Organ-Chip Platform
BOSTON--(BUSINESS WIRE)--Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent Organ-Chip samples in a single run. AVA delivers an unprecedented magnitude of in vivo -level insights faster than animal models while cutting consumable costs four-fold and in-lab labor by half compared to current generation technologies. These transformative capabilities give the pharmaceutical industry the practical means to pivot beyond animal testing and into truly human-relevant territory. With the FDA targeting animal studies to become 'the exception rather than the norm,' the need for proven human models is urgent. Emulate's Liver-Chip S1—the first and only Organ-Chip admitted to the FDA's ISTAND program. Share 'AVA gives scientists unprecedented experimental capacity with the biological depth of live human tissue—something no other platform can match,' said Jim Corbett, Chief Executive Officer at Emulate. 'By combining Emulate's proven Organ-on-a-Chip technology with high-throughput consumables, automated imaging, and streamlined workflows in one benchtop unit, AVA lets teams ask bigger questions earlier and move the right drug candidates forward faster.' AVA Emulation System: Three Instruments in One AVA is the first self-contained Organ-on-a-Chip workstation to fuse high-throughput microfluidic tissue culture, full environmental control, and real-time imaging into a single, compact benchtop unit. Key performance gains include: Expanded experimental power – 96 independent Organ-Chip samples in a single run enable researchers to achieve microplate-level scale of their Organ-Chip experiments, enabling side-by-side comparison of dozens of compounds, doses, or stimuli. Lower operating costs – AVA achieves a four-fold drop in consumable spend and up to 50% fewer cells and media per sample compared to previous generation technology. Time & labor savings – Hands-on, in-lab time is reduced by more than half, thanks to automated microscopy, remote monitoring, and the revolutionary new Chip-Array™ consumable that integrates 12 independent Organ-Chips into an SBS format for streamlined workflows with multichannel pipettes and automated liquid handlers. AI-ready datasets – A typical 7-day experiment can generate >30,000 time-stamped data points from daily imaging and effluent assays, with post-takedown omics pushing the total into the millions—providing a rich, multi-modal foundation to feed machine-learning pipelines for target discovery, lead optimization, and safety prediction. A Timely Answer to Shifting Regulations With the FDA targeting animal studies to become 'the exception rather than the norm,' the need for proven human models is urgent. Emulate's Liver-Chip S1—the first and only Organ-Chip admitted to the FDA's ISTAND program—has already outperformed animals, showing 87% sensitivity and 100% specificity for drug-induced liver injury in a 2022 Communications Medicine study. AVA now scales that level of human relevance across discovery, efficacy, and toxicology screens, accelerating safer therapies through the pipeline. 'Moving towards reduction and in some cases replacement of animal models demands both biological fidelity and throughput,' noted Dr. Lorna Ewart, Emulate Chief Scientific Officer. 'AVA meets those dual requirements, empowering teams to rank-order lead candidates, pinpoint off-target toxicities, and advance safer therapies with unprecedented speed and confidence.' Broad Impact Across Industries In biopharma, this type of reduction and replacement is already a reality. A leading pharmaceutical company has demonstrated the power of implementing Organ-Chips into their development pipeline when one of their scientists saved millions of dollars and years of development time by using Emulate Liver-Chips ahead of non-human primates to screen lipid-nanoparticle (LNP) candidates. AVA's leap in throughput of predictive human biology stands to benefit not only biopharma but a wide spectrum of sectors that currently rely on inaccurate animal testing. Large pharmaceutical pipelines can now run comparable screens in a single AVA experiment, while smaller biotech teams gain enterprise-level capacity without adding headcount or infrastructure. Beyond therapeutics, contract research organizations, consumer-product companies, and environmental agencies can harness AVA to evaluate industrial chemicals, food additives, and cosmetic ingredients under human-relevant conditions—bringing faster, more ethical safety and efficacy decisions to market-driven and regulatory programs alike. Availability Global orders are open immediately. For pricing or demonstrations, please submit a request here. About Emulate Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, enabling researchers to accurately replicate human tissue function and disease biology through next generation in vitro models. From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate's Organ-Chip platforms, consumables, and organ models help the world's leading pharmaceutical, biotech, and academic teams generate human-relevant data that advance safer, more effective therapies. Learn more at
2 hours ago
World Cup host city organizers acknowledge immigration crackdown may impact next year's tournament
NEW YORK -- Philadelphia's host city executive for the 2026 World Cup says organizers accept that an immigration crackdown by President Donald Trump's administration may be among the outside events that impact next year's tournament. "There are certainly things that are happening at the national level, the international level, there are going to be geopolitical issues that we don't even know right now that are going affect the tournament next year, so we recognize that we're planning within uncertainty,' Meg Kane said Monday at a gathering of the 11 U.S. host city leaders, one year and two days ahead of the tournament opener. The World Cup will be played at 16 stadiums in the U.S., Mexico and Canada from June 11 to July 19 next year, a tournament expanded to 48 nations and 104 games. All matches from the quarterfinals on will be in the U.S., with the final at MetLife Stadium in East Rutherford, New Jersey. 'Whether it's the Olympics, whether it's a World Cup, whether it's a Super Bowl, you name it, anytime you've got a major international sporting event, geopolitics is going to have a role,' said Alex Vasry, CEO of the New York/New Jersey host committee. Kane said the host committees must adapt to decisions made by others. 'One of the things that I think we all recognize is that we have to be really good at operating within that uncertainty,' Kane said. 'I think for each of our cities, we want to be prepared to make any person that is coming and makes the decision to come to the United States or come to this World Cup feel that they are welcome. We do not play a role necessarily in what is happening in terms of the decisions that are made.' Trump's travel ban on citizens from 12 countries exempted athletes, coaches, staff and relatives while not mentioning fans. 'We allow for FIFA to continue having constructive conversations with the administrations around visas, around workforce, around tourism,' Kane said. FIFA is running the World Cup for the first time without a local organizing committee in the host nation. Asked in late April whether FIFA president Gianni Infantino was available to discuss the tournament, FIFA director of media relations Bryan Swanson forwarded the request to a member of the media relations staff, who did not make Infantino available. Legislation approved by the House of Representatives and awaiting action in the Senate would appropriate $625 million to the Federal Emergency Management Agency 'for security, planning, and other costs related to the 2026 FIFA World Cup.' The 11 U.S. host committees have been consulting with each other on issues such as transportation for teams and VIPs, and for arranging fan fests. At the last major soccer tournament in the U.S., the 2024 Copa America final at Hard Rock Stadium in Miami Gardens, Florida, started 82 minutes late after fans breached security gates. 'Certainly we were not involved in the planning or the logistics for that particular match,' said Alina Hudak, CEO of the Miami World Cup host committee. She said local police 'have done an extensive review of the after-action reports related to that in collaboration with the stadium and so all of the things that happened are in fact being reviewed and addressed and I can assure you that everything is being done within our power to make sure that the appropriate measures are being placed, the appropriate perimeters.'
Yahoo
6 hours ago
- Yahoo
Summer McIntosh breaks world record in 200m individual medley
Summer McIntosh broke the world record in the 200m individual medley, giving her the fastest time in history in three different long course swimming events. McIntosh, a triple 2024 Olympic gold medalist, clocked 2 minutes, 5.70 seconds on Monday at the Canadian trials for the World Championships in Singapore in July and August. Advertisement She broke the world record of 2:06.12 set by Hungarian Katinka Hosszu at the 2015 World Championships, the third-longest standing world record in women's long course (50-meter pool) swimming. McIntosh, 18, was previously the third-fastest 200m IMer in history thanks to her 2:06.56 to win Paris Olympic gold. With Monday's time, she passed American Ariana Kukors, who swam 2:06.15 at the 2009 Worlds, and Hosszu. McIntosh also owns world records in the 400m IM (set in 2024) and the 400m freestyle (reclaimed from Australian Ariarne Titmus last Saturday). On Sunday, she swam the third-fastest 800m free in history, trailing only Katie Ledecky's top two times. She also owns the second-fastest time in history in the 200m butterfly. Advertisement For this season's worlds, McIntosh said she plans to swim five individual events: her three Olympic gold-medal events — both IMs, 200m fly — plus the 400m free and one of the 200m free, 200m backstroke or 800m free. Michael Phelps is the only swimmer to win five individual golds at a single worlds, doing so in 2007 to set the table for repeating the feat at the 2008 Beijing Olympics, where he also won three relay golds for eight total. Paris 2024 Olympic Games - Day One Ariarne Titmus: 'I know that the LA Olympics will be my last' Ariarne Titmus won two swimming gold medals for Australia at Tokyo 2020 and at Paris 2024.
